Cited 0 times in
Leukotriene Receptor Antagonists for the Treatment of Asthma in Elderly Patients
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Trinh, HK | - |
dc.contributor.author | Ban, GY | - |
dc.contributor.author | Lee, JH | - |
dc.contributor.author | Park, HS | - |
dc.date.accessioned | 2018-05-04T00:25:30Z | - |
dc.date.available | 2018-05-04T00:25:30Z | - |
dc.date.issued | 2016 | - |
dc.identifier.issn | 1170-229X | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/15010 | - |
dc.description.abstract | Elderly asthma (EA) is regarded as a distinct phenotype of asthma and is associated with age-related changes in airway structure and alterations in lung function and immune responses. EA is difficult to diagnose because of aging and co-morbidities, and overlaps with fixed airway obstructive disease. Novel modalities to differentiate between EA and chronic obstructive pulmonary disease (COPD) are necessary. A multifaceted approach, including clinical history, smoking habits, atopy, and measurement of lung function, is mandatory to differentiate asthma from COPD. There are a variety of co-morbidities with EA, of which COPD, upper airway diseases, depression, obesity, and hypertension are the most common, and these co-morbidities can affect the control status of EA. However, leukotriene receptor antagonists (LTRAs) can facilitate the management of EA, and thus addition of an LTRA to inhaled corticosteroid (ICS) monotherapy or ICS plus long-acting beta2-agonist therapy improves symptoms in EA patients. LTRA treatment is safe and beneficial in patients who are unable to use inhalation devices properly or who have co-morbid diseases. Therefore, clinical studies targeting a specific population of EA patients are warranted to help achieve a better therapeutic strategy in EA patients. | - |
dc.language.iso | en | - |
dc.subject.MESH | Administration, Inhalation | - |
dc.subject.MESH | Administration, Oral | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Aging | - |
dc.subject.MESH | Anti-Asthmatic Agents | - |
dc.subject.MESH | Asthma | - |
dc.subject.MESH | Clinical Trials as Topic | - |
dc.subject.MESH | Comorbidity | - |
dc.subject.MESH | Diagnosis, Differential | - |
dc.subject.MESH | Drug Therapy, Combination | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Leukotriene Antagonists | - |
dc.subject.MESH | Pulmonary Disease, Chronic Obstructive | - |
dc.title | Leukotriene Receptor Antagonists for the Treatment of Asthma in Elderly Patients | - |
dc.type | Article | - |
dc.identifier.pmid | 27709465 | - |
dc.contributor.affiliatedAuthor | 반, 가영 | - |
dc.contributor.affiliatedAuthor | 이, 지호 | - |
dc.contributor.affiliatedAuthor | 박, 해심 | - |
dc.type.local | Journal Papers | - |
dc.identifier.doi | 10.1007/s40266-016-0401-2 | - |
dc.citation.title | Drugs & aging | - |
dc.citation.volume | 33 | - |
dc.citation.number | 10 | - |
dc.citation.date | 2016 | - |
dc.citation.startPage | 699 | - |
dc.citation.endPage | 710 | - |
dc.identifier.bibliographicCitation | Drugs & aging, 33(10). : 699-710, 2016 | - |
dc.embargo.liftdate | 9999-12-31 | - |
dc.embargo.terms | 9999-12-31 | - |
dc.identifier.eissn | 1179-1969 | - |
dc.relation.journalid | J01170229X | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.